Biocatalytic drugs, including natural and artificial enzymes that can accelerate biochemical
reactions, are promising tools to address redox imbalances, metabolic disorders and …

Osteoporosis is a systemic skeletal disease caused by an imbalance between bone
resorption and formation. Current treatments primarily involve systemic medication and …

Environmental benzo (a) pyrene (BaP) and its ultimate metabolite BPDE (benzo (a) pyrene-
7, 8-dihydrodiol-9, 10-epoxide) are universal and inevitable persistent organic pollutants …

The use of oxidoreductase nanozymes to regulate reactive oxygen species (ROS) has
gradually emerged in periodontology treatments. However, current nanozymes for treating …

The repair of large bone defects due to trauma, disease, and infection can be exceptionally
challenging in the elderly. Despite best clinical practice, bone regeneration within …

Reducible metal oxide nanozymes (rNZs) are a subject of intense recent interest due to their
catalytic nature, ease of synthesis, and complex surface character. Such materials contain …

Cerium oxide nanoparticles (CeONPs) have come to prominence as a highly intriguing and
beneficial nanomaterial in an array of biomedical and theranostic applications, including …

Interest in space exploration has seen substantial growth following recent launch and
operation of modern space technologies. In particular, the possibility of travel beyond low …

The prevalence of neurological dieases, including neurodegenerative, neurotraumatic
disorders, and neuroinflammatory conditions, has been rising due to global population and …

With the discovery of the intrinsic enzyme‐like activity of metal oxides, nanozymes garner
significant attention due to their superior characteristics, such as low cost, high stability, multi …